Further work found that this increase in Cai2+ was mediated by the binding of TP53 to the TRPC6 promoter, resulting in the overexpression of TRPC6, enhancing Ca2+-dependent apoptosis in MCF-7 BC cells[78]. Here, TRPC6 is linked to breast cancer.